Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
NewGenIvf Group Limited Class A Ordinary Shares (NIVF)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/15/2025: NIVF (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -1.52% | Avg. Invested days 109 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/15/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 4.45M USD | Price to earnings Ratio - | 1Y Target Price - |
Price to earnings Ratio - | 1Y Target Price - | ||
Volume (30-day avg) - | Beta 0.13 | 52 Weeks Range 0.26 - 45.40 | Updated Date 06/29/2025 |
52 Weeks Range 0.26 - 45.40 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -293.1 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -9.66% | Operating Margin (TTM) -85.51% |
Management Effectiveness
Return on Assets (TTM) -17.99% | Return on Equity (TTM) -53.76% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 7113172 | Price to Sales(TTM) 0.82 |
Enterprise Value 7113172 | Price to Sales(TTM) 0.82 | ||
Enterprise Value to Revenue 1.31 | Enterprise Value to EBITDA 294.99 | Shares Outstanding 4304040 | Shares Floating 112699 |
Shares Outstanding 4304040 | Shares Floating 112699 | ||
Percent Insiders 2.24 | Percent Institutions 0.55 |
Upturn AI SWOT
NewGenIvf Group Limited Class A Ordinary Shares
Company Overview
History and Background
NewGenIvf Group Limited, founded in 2020, is focused on fertility services in Southeast Asia. It aims to enhance IVF treatment outcomes through technological advancements.
Core Business Areas
- Fertility Services: Offers a comprehensive range of assisted reproductive technology (ART) services, including IVF, ICSI, and fertility preservation.
Leadership and Structure
Details about the leadership team and organizational structure were not readily available.
Top Products and Market Share
Key Offerings
- IVF Treatments: The core offering, utilizing advanced technologies. The Southeast Asian fertility market is competitive, with regional players like Thomson Medical Group and Raffles Medical Group. Specific market share data for NewGenIvf is limited.
- ICSI Treatments: The core offering, utilizing advanced technologies. The Southeast Asian fertility market is competitive, with regional players like Thomson Medical Group and Raffles Medical Group. Specific market share data for NewGenIvf is limited.
- Fertility Preservation: Offering egg freezing and sperm freezing services. Competitors include Virtus Health and Monash IVF. Market share data is not easily accessible.
Market Dynamics
Industry Overview
The fertility services market is growing due to rising infertility rates, delayed parenthood, and technological advancements.
Positioning
NewGenIvf aims to differentiate itself through technology and personalized treatment plans. Information on how that works is not public.
Total Addressable Market (TAM)
The global fertility services market is estimated to be several billion USD, and is growing. NewGenIvf's position is dependent on its ability to capture market share in Southeast Asia.
Upturn SWOT Analysis
Strengths
- Focus on technological innovation
- Experienced medical team (assumed)
- Strategic location in Southeast Asia
Weaknesses
- Limited brand recognition
- Dependence on Southeast Asian market
- Smaller scale compared to established players
Opportunities
- Expansion into new markets
- Partnerships with other healthcare providers
- Adoption of telehealth solutions
Threats
- Intense competition
- Regulatory changes
- Economic downturns affecting affordability
Competitors and Market Share
Key Competitors
- THOMSON MEDICAL GROUP (TMPG.SI)
- RAFFLES MEDICAL GROUP (BSL.SI)
- Virtus Health
- Monash IVF
Competitive Landscape
NewGenIvf competes with both local and international players. Its success depends on its ability to offer competitive pricing and advanced treatments. Disadvantages include a lack of brand recognition.
Growth Trajectory and Initiatives
Historical Growth: Historical growth data is limited due to the company's relatively recent founding.
Future Projections: Future growth projections are dependent on market conditions and the company's execution of its strategy.
Recent Initiatives: Information on recent strategic initiatives is not readily available.
Summary
NewGenIvf Group Limited is a relatively new player in the fertility services market, aiming to innovate through technology. While it faces strong competition and lacks brand recognition, its focus on the growing Southeast Asian market presents opportunities for growth. Success will depend on its ability to execute its strategy effectively and differentiate itself. More access to the financial statements will improve a company's fundamentals.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company website
- Industry reports
- Market analysis
Disclaimers:
The data and analysis provided are based on publicly available information and are for informational purposes only. They do not constitute investment advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About NewGenIvf Group Limited Class A Ordinary Shares
Exchange NASDAQ | Headquaters - | ||
IPO Launch date 2024-04-03 | Co-Founder, Chairman & CEO Mr. Wing Fung Siu | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 76 | Website https://newgenivf.com |
Full time employees 76 | Website https://newgenivf.com | ||
NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company's fertility treatment solutions include in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screening, hysteroscopy, sperm analysis, sorting, washing, and freezing, and egg freezing. It also provides IVF treatment; surrogacy and ancillary caring services, including regular body check, as well as vitamins, supplements, and medicines to surrogate mothers; and value-added services comprising nutrition guidance, psychological counselling, acupuncture, and translation interpreters to supplement the IVF treatment. The company offers its services through its clinics. NewGenIvf Group Limited was founded in 2010 and is based in Bangkok, Thailand.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.